NANO MRNA Co.,Ltd. (FRA:3NQ)
Germany
· Delayed Price · Currency is EUR 0.800
0.00 (0.00%)
At close: Dec 5, 2025
NANO MRNA Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2010 | FY 2009 | 2008 - 2006 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '10 Mar 31, 2010 | Mar '09 Mar 31, 2009 | 2008 - 2006 |
| Revenue | 142 | 108 | 135 | 202 | 117.82 | 353.65 | Upgrade
|
| Revenue Growth (YoY) | 178.43% | -20.00% | -33.17% | 71.45% | -66.68% | 34.61% | Upgrade
|
| Cost of Revenue | 39 | 30 | 24 | 43 | 70.93 | 247.31 | Upgrade
|
| Gross Profit | 103 | 78 | 111 | 159 | 46.89 | 106.34 | Upgrade
|
| Selling, General & Admin | 461 | 411 | 328 | 285 | 320.35 | 310.04 | Upgrade
|
| Research & Development | 422 | 422 | 647 | 1,120 | 219.23 | 295.59 | Upgrade
|
| Other Operating Expenses | - | - | - | - | - | 32.51 | Upgrade
|
| Operating Expenses | 883 | 833 | 975 | 1,405 | 539.59 | 638.15 | Upgrade
|
| Operating Income | -780 | -755 | -864 | -1,246 | -492.7 | -531.81 | Upgrade
|
| Interest Expense | - | - | - | -5 | - | - | Upgrade
|
| Interest & Investment Income | 30 | 31 | 26 | 25 | 2.84 | 7.35 | Upgrade
|
| Currency Exchange Gain (Loss) | 20 | -4 | 54 | 60 | 0.44 | -0.07 | Upgrade
|
| Other Non Operating Income (Expenses) | 40 | 40 | 34 | 61 | -3.93 | 1.36 | Upgrade
|
| EBT Excluding Unusual Items | -690 | -688 | -750 | -1,105 | -493.34 | -523.18 | Upgrade
|
| Gain (Loss) on Sale of Investments | -10 | -144 | 42 | -268 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 1 | 4 | - | 1.66 | Upgrade
|
| Asset Writedown | -1 | -1 | -71 | -6 | -0.03 | -0.03 | Upgrade
|
| Other Unusual Items | -54 | - | - | 67 | 1 | -0.52 | Upgrade
|
| Pretax Income | -755 | -833 | -778 | -1,308 | -492.37 | -522.06 | Upgrade
|
| Income Tax Expense | 2 | 2 | 2 | 2 | 2.42 | 2.42 | Upgrade
|
| Net Income | -757 | -835 | -780 | -1,310 | -494.79 | -524.48 | Upgrade
|
| Net Income to Common | -757 | -835 | -780 | -1,310 | -494.79 | -524.48 | Upgrade
|
| Shares Outstanding (Basic) | 71 | 71 | 70 | 70 | 13 | 13 | Upgrade
|
| Shares Outstanding (Diluted) | 71 | 71 | 70 | 70 | 13 | 13 | Upgrade
|
| Shares Change (YoY) | 0.52% | 0.32% | 0.29% | 448.88% | 2.13% | 38.31% | Upgrade
|
| EPS (Basic) | -10.70 | -11.84 | -11.10 | -18.69 | -38.75 | -41.95 | Upgrade
|
| EPS (Diluted) | -10.70 | -11.84 | -11.10 | -18.69 | -38.75 | -41.95 | Upgrade
|
| Free Cash Flow | -445 | -401 | -585 | -1,087 | -454.43 | -459.59 | Upgrade
|
| Free Cash Flow Per Share | -6.29 | -5.69 | -8.32 | -15.51 | -35.59 | -36.76 | Upgrade
|
| Gross Margin | 72.54% | 72.22% | 82.22% | 78.71% | 39.80% | 30.07% | Upgrade
|
| Operating Margin | -549.30% | -699.07% | -640.00% | -616.83% | -418.18% | -150.38% | Upgrade
|
| Profit Margin | -533.10% | -773.15% | -577.78% | -648.51% | -419.95% | -148.31% | Upgrade
|
| Free Cash Flow Margin | -313.38% | -371.30% | -433.33% | -538.12% | -385.70% | -129.96% | Upgrade
|
| EBITDA | - | -754 | -863 | - | -479.59 | -516.05 | Upgrade
|
| EBITDA Margin | - | - | - | - | - | -145.92% | Upgrade
|
| D&A For EBITDA | - | 1 | 1 | - | 13.1 | 15.76 | Upgrade
|
| EBIT | -780 | -755 | -864 | -1,246 | -492.7 | -531.81 | Upgrade
|
| EBIT Margin | - | - | - | - | - | -150.38% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.